手术视频
关于我们
联系我们
中心官网
泌尿系统常见疾病循证医学证据
首页
良性前列腺增生
泌尿系统感染
泌尿系统结石
前列腺炎
前列腺癌
膀胱肿瘤
肾癌
其他
首页
搜索结果
证据分类
良性前列腺增生
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
手术视频
调查问卷
泌尿系统感染
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
泌尿系统结石
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺炎
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
前列腺癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
膀胱肿瘤
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
肾癌
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
其他
病因/危险因素证据
诊断证据
治疗及预后证据
预防证据
临床路径
临床实践指南
搜索结果
按关键字
按标题
按关键词
按摘要
按作者
按期刊
共搜索到
5条
与
Hal
有关的结果
Outcomes and complications of naftopidil versus tamsulosin for elderly men with lower urinary tract symptoms secondary to benign prostatic hyperplasia: A systematic review and meta-analysis
2021年 发布于
Andrologia
53卷 第9期
Chai
Y. Zhou
Z. Cui
Y. Che
X. Zhang
Y.
Aged
Humans
*Lower Urinary Tract Symptoms
Male
Naphthalenes
Piperazines
Prospective Studies
*Prostatic Hyperplasia
Quality of Life
Sulfonamides
Tamsulosin
Treatment Outcome
benign prostatic hyperplasia
lower urinary tract symptoms
naftopidil
tamsulosin
文献简介
原文链接
Naftopidil for the treatment of lower urinary tract symptoms compatible with benign prostatic hyperplasia
2018年 发布于
Cochrane Database Syst Rev
10卷 第10期
Hwang
E. C. Gandhi
S. Jung
J. H. Imamura
M. Kim
M. H. Pang
R. Dahm
P.
Adrenergic alpha-Antagonists
Benzilates
Drug Combinations
Ethamsylate
Humans
Indoles
Lower Urinary Tract Symptoms
Male
Naphthalenes
Piperazines
Plant Extracts
Prostatic Hyperplasia
Prostatism
Quality of Life
Randomized Controlled Trials as Topic
Sulfonamides
Tamsulosin
Urological Agents
文献简介
原文链接
Silodosin for the treatment of lower urinary tract symptoms in men with benign prostatic hyperplasia
2017年 发布于
Cochrane Database Syst Rev
11卷 第11期
Jung
J. H. Kim
J. MacDonald
R. Reddy
B. Kim
M. H. Dahm
P.
Adrenergic alpha-1 Receptor Antagonists
Aged
Humans
Indoles
Lower Urinary Tract Symptoms
Male
Naphthalenes
Piperazines
Prostatic Hyperplasia
Quinazolines
Randomized Controlled Trials as Topic
Urological Agents
文献简介
原文链接
荟萃分析:机器人辅助与腹腔镜膀胱癌根治术的临床疗效对比
2021 年 发布于
中国医学前沿杂志 ( 电子版 )
79 卷 第 4 期
庄东武
5-ala
5-aminolaevulinic acid
Hal
Pdd
accuracy meta-analysis
bladder cancer
blue light cystoscopy
cystoscopy
hexaminolevulinate
narrow band imaging
photodynamic diagnosis fluorescence
consultant for Janssen
Ferring
Photocure
Taris
Spectrum
Pacific Edge
QED
Abbvie
Johnson & Johnson
Seattle Genetics
Nucleix
Aduro
and BMS. Ashish
Kamat is is a consultant for Photocure. Mihir Desai is a consultant for Procept
Biorobotics and Auris Surgical. Yair Lotan is a consultant for Photocure. Angela
Smith is an investigator for Urogen and a consultant for FerGene
Urogen
and
Merck.
文献简介
原文链接
Risk factors for loco-regional recurrence after radical cystectomy of muscle invasive bladder cancer: A systematic-review and framework for adjuvant radiotherapy
2018 年 发布于
Urol Oncol
14 卷 第 4 期
Sargos P.
Baumann B. C.
Eapen L.
Christodouleas J.
Bahl A.
Murthy V.
Efstathiou J.
Fonteyne V.
Ballas L.
Zaghloul M.
Roubaud G.
Orre M.
Larre S.
Administration
Intravesical
Antineoplastic Agents/*administration & dosage
Antineoplastic Combined Chemotherapy Protocols/administration & dosage
Carcinoma
Transitional Cell/*drug therapy/mortality
Cyclophosphamide/administration & dosage
Doxorubicin/administration & dosage/analogs & derivatives
Epirubicin/administration & dosage
Humans
Melphalan/administration & dosage
Network Meta-Analysis
Semustine/administration & dosage
Treatment Outcome
Urinary Bladder Neoplasms/*drug therapy/mortality
chemotherapy
drug therapy
single instillation
systematic review
urinary bladder neoplasm
文献简介
原文链接